Andrew Briggs Selected Research

Andrew Briggs Research Topics

Disease

6	Neoplasms (Cancer) 01/2022 - 01/2007
6	Stroke (Strokes) 01/2015 - 05/2005
5	Chronic Obstructive Pulmonary Disease (COPD) 04/2022 - 06/2015
4	Heart Failure 04/2022 - 01/2018
4	Myocardial Infarction 11/2020 - 05/2005
4	Infections 01/2019 - 01/2007
4	Vascular Diseases (Vascular Disease) 06/2013 - 05/2005
3	COVID-19 05/2022 - 11/2021
3	Disease Progression 01/2022 - 01/2011
3	Type 2 Diabetes Mellitus (MODY) 01/2021 - 06/2013
3	Hypersensitivity (Allergy) 12/2020 - 01/2007
3	Coronary Artery Disease (Coronary Atherosclerosis) 11/2020 - 04/2006
3	Cardiovascular Diseases (Cardiovascular Disease) 11/2019 - 09/2007
3	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2018 - 01/2018
3	Coronary Disease (Coronary Heart Disease) 06/2013 - 04/2006
2	Chronic Renal Insufficiency 04/2022 - 09/2020
2	Breast Neoplasms (Breast Cancer) 01/2022 - 12/2020
2	Schizophrenia (Dementia Praecox) 01/2022 - 11/2008
2	Lung Neoplasms (Lung Cancer) 01/2021 - 11/2017
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2018
2	Pathologic Complete Response 12/2020 - 01/2020
2	Melanoma (Melanoma, Malignant) 12/2020 - 11/2020
2	Allergic Rhinitis 12/2020 - 01/2020
2	Shock 11/2020 - 02/2016
2	Psoriatic Arthritis 11/2019 - 01/2011
2	Hemorrhage 01/2018 - 01/2018
2	Weight Loss (Weight Reduction) 12/2017 - 05/2015
2	Intellectual Disability (Idiocy) 12/2017 - 12/2015
1	Heart Diseases (Heart Disease) 04/2022
1	Diabetes Mellitus 04/2022
1	Atrial Fibrillation 01/2022
1	Asthma (Bronchial Asthma) 01/2021
1	Seasonal Allergic Rhinitis (Hay Fever) 12/2020
1	Cardiogenic Shock 11/2020
1	Triple Negative Breast Neoplasms 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2020

Drug/Important Bio-Agent (IBA)

6	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2022 - 06/2015
4	Anti-Bacterial Agents (Antibiotics)IBA 04/2022 - 06/2015
4	Pharmaceutical PreparationsIBA 11/2021 - 01/2018
3	larotrectinibIBA 01/2022 - 11/2020
3	eltrombopag FDA Link 01/2018 - 01/2018
3	romiplostim FDA Link 01/2018 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 04/2022 - 01/2021
2	Bronchodilator Agents (Bronchodilators)IBA 04/2022 - 06/2015
2	Phosphotransferases (Kinase)IBA 01/2022 - 11/2020
2	sacubitril and valsartan sodium hydrate drug combinationIBA 11/2021 - 01/2018
2	AutoantibodiesIBA 01/2021 - 11/2017
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 01/2018
2	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 01/2021
2	lenvatinibIBA 01/2020 - 01/2016
2	GSK573719IBA 12/2018 - 01/2018
2	BromidesIBA 12/2018 - 01/2018
2	Theophylline (Theon)FDA LinkGeneric 10/2018 - 06/2015
2	Thrombopoietin ReceptorsIBA 01/2018 - 01/2018
2	Perindopril FDA LinkGeneric 09/2007 - 04/2006
2	Simvastatin (Zocor)FDA LinkGeneric 12/2006 - 05/2005
1	Monoclonal AntibodiesIBA 05/2022
1	casirivimab and imdevimab drug combinationIBA 05/2022
1	Bisoprolol (Concor)FDA LinkGeneric 04/2022
1	tyrosine receptor (receptor, tyrosine)IBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Letrozole (Femara)FDA LinkGeneric 01/2022
1	molnupiravirIBA 01/2022
1	Anastrozole (Arimidex)FDA LinkGeneric 01/2022
1	AldosteroneIBA 11/2021
1	AngiotensinsIBA 11/2021
1	Mineralocorticoid Receptor AntagonistsIBA 11/2021
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 11/2021
1	ReninIBA 11/2021
1	VaccinesIBA 11/2021
1	Neprilysin (Neutral Endopeptidase)IBA 11/2021
1	vericiguatIBA 11/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Sitagliptin Phosphate (Januvia)FDA Link 01/2021
1	semaglutideIBA 01/2021
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2021
1	SodiumIBA 01/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021
1	ragweed pollenIBA 12/2020
1	TropomyosinIBA 11/2020
1	pembrolizumabIBA 11/2020
1	Sorafenib (BAY 43-9006)FDA Link 01/2020
1	AllergensIBA 01/2020
1	TroponinIBA 11/2019
1	PropionatesIBA 12/2018
1	Muscarinic AntagonistsIBA 12/2018

Therapy/Procedure

27	Therapeutics 04/2022 - 07/2002
4	Percutaneous Coronary Intervention 11/2020 - 01/2015
3	Drug Therapy (Chemotherapy) 01/2021 - 01/2007
2	Palliative Care (Palliative Therapy) 01/2022 - 01/2011
2	Neoadjuvant Therapy 12/2020 - 01/2020
2	Immunotherapy 12/2020 - 01/2020
2	Renal Replacement Therapy (Therapies, Renal Replacement) 09/2020 - 02/2016
2	Stem Cell Transplantation 01/2017 - 03/2009
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2016 - 01/2015
1	Secondary Prevention 01/2022
1	Duration of Therapy 01/2022
1	Terminal Care (Care, Terminal) 11/2021
1	Glycemic Control 01/2021
1	Lymph Node Excision (Lymph Node Dissection) 12/2020